These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16595706)

  • 21. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
    Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
    Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of interdomain interactions of the androgen receptor.
    Wilson EM
    Methods Mol Biol; 2011; 776():113-29. PubMed ID: 21796524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design.
    Bohl CE; Wu Z; Miller DD; Bell CE; Dalton JT
    J Biol Chem; 2007 May; 282(18):13648-55. PubMed ID: 17311914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen receptor mutations causing human androgen insensitivity syndromes show a key role of residue M807 in Helix 8-Helix 10 interactions and in receptor ligand-binding domain stability.
    Ong YC; Kolatkar PR; Yong EL
    Mol Hum Reprod; 2002 Feb; 8(2):101-8. PubMed ID: 11818512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
    Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
    Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new mutation of the androgen receptor, P817A, causing partial androgen insensitivity syndrome: in vitro and structural analysis.
    Lumbroso S; Wagschal A; Bourguet W; Georget V; Mazen I; Servant N; Audran F; Sultan C; Auzou G
    J Mol Endocrinol; 2004 Jun; 32(3):679-87. PubMed ID: 15171708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor.
    Shen HC; Buchanan G; Butler LM; Prescott J; Henderson M; Tilley WD; Coetzee GA
    Biol Chem; 2005 Jan; 386(1):69-74. PubMed ID: 15843149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2.
    Helsen C; Nguyen T; Vercruysse T; Wouters S; Daelemans D; Voet A; Claessens F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of persistent organic pollutants binding modes with androgen receptor ligand binding domain by docking and molecular dynamics.
    Xu XJ; Su JG; Bizzarri AR; Cannistraro S; Liu M; Zeng Y; Chen WZ; Wang CX
    BMC Struct Biol; 2013 Sep; 13():16. PubMed ID: 24053684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
    Deeb A; Jääskeläinen J; Dattani M; Whitaker HC; Costigan C; Hughes IA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3691-6. PubMed ID: 18697867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer.
    Southwell J; Chowdhury SF; Gottlieb B; Beitel LK; Lumbroso R; Purisima EO; Trifiro M
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):138-46. PubMed ID: 18619542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactions.
    Kaczmarczyk SJ; Green JE
    Nucleic Acids Res; 2003 Aug; 31(15):e86. PubMed ID: 12888538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.
    Alen P; Claessens F; Verhoeven G; Rombauts W; Peeters B
    Mol Cell Biol; 1999 Sep; 19(9):6085-97. PubMed ID: 10454556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions.
    Schaufele F; Carbonell X; Guerbadot M; Borngraeber S; Chapman MS; Ma AA; Miner JN; Diamond MI
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9802-7. PubMed ID: 15994236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
    Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
    Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer.
    Helsen C; Rocca MS; Nguyen TT; Eerlings R; Lee XY; De Block S; Vinanzi C; Di Millo F; Giagulli V; Voet A; Ferlin A; Claessens F
    Protein Sci; 2023 Apr; 32(4):e4599. PubMed ID: 36806291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of androgen receptor structure and nucleocytoplasmic shuttling of the rice field eel.
    Zhou F; Zhao W; Zuo Z; Sheng Y; Zhou X; Hou Y; Cheng H; Zhou R
    J Biol Chem; 2010 Nov; 285(47):37030-40. PubMed ID: 20841357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities.
    Vivat V; Gofflo D; Garcia T; Wurtz JM; Bourguet W; Philibert D; Gronemeyer H
    J Mol Endocrinol; 1997 Apr; 18(2):147-60. PubMed ID: 9134501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter-dependent activity on androgen receptor N-terminal domain mutations in androgen insensitivity syndrome.
    Tadokoro-Cuccaro R; Davies J; Mongan NP; Bunch T; Brown RS; Audi L; Watt K; McEwan IJ; Hughes IA
    Sex Dev; 2014; 8(6):339-49. PubMed ID: 25500996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.